Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination

Research output: Contribution to conferenceAbstract

Abstract

Background: Congenital hyperinsulinism (CHI) is the most
common cause of persistent hypoglycemia in infancy, characterized by unregulated insulin secretion. CHI is a challenging
disease to diagnose and manage. Moreover, complicating the
course of the disease with another metabolic disease like Maple
syrup urine disease (MSUD) adds more challenges to the already
complex management. Case: We report a term male neonate with
uneventful birth history. He developed symptomatic hypoglycemia with a blood glucose (BG) level of 1.9 mmol/l at 21 hours of
life. A critical sample at that time showed high serum insulin of 167.7 pmol/L, C-peptide [1160 pmol/L and low ketones
confirming the diagnosis of hyperinsulinism. Amino acid profile
on dried blood spot by tandem mass spectrometry part of critical
sample was done and showed high leucine and isoleucine levels
indicating the diagnosis of MSUD. MSUD is then confirmed by
HPLC which showed the presence of allo-isoleucine at
101 umol/L, and elevated levels of the three branched chain
amino acids (leucine 724 (45.00–160.00), isoleucine 240 umol/L
(28.00–95.00), and valine 390 umol/L (60.00–294.00). The
diagnosis of CHI and MSUD was afterward confirmed by
molecular genetic testing. The finding of a known pathogenic
homozygous mutation in the ABCC8 gene (c.3748COT,
p.Arg1250*) confirmed CHI diagnosis. The presence of a
homozygous mutation in the BCKDHA (c.1087, p.Arg363Trp)
confirmed the MSUD diagnosis. The baby’s case is very
challenging managing two rare autosomal recessive disorders.
Managing his hypoglycemia with high glucose rate through
intravenous fluids, frequent feeds with special MSUD formula, and
medications for hyperinsulinism (Diazoxide and octereotide).
Unfortunately his hyperinsulinism did not respond to all medical
measures and he needed to go to a near total pancreatectomy.
Through all his complicated course, he required very meticulous
monitoring of his BG and amino acid profile (3 times/week on
average) aiming to maintain the BG at 3.9 mmol and above and
levels of the three branched chain amino acids at the disease
therapeutic targets for a neonate. Conclusion: This patient is
perhaps the only known case of the occurrence of two rare life
threatening disorders. Both hypoglycemia and Leucine encephalopathy can result in death or permanent neurological damage. This
is complicated by the fact that both disorders have direct effect on
the body metabolism of glucose and branched chain amino acids
and there management in combination is very challenging
Original languageEnglish
Pages359
Publication statusPublished - 2018
Event European society of pediatric endocrinology meeting 2018 - Athens , Greece
Duration: Sep 27 2018Sep 29 2018

Conference

Conference European society of pediatric endocrinology meeting 2018
Abbreviated titleESPE 2018
CountryGreece
CityAthens
Period9/27/189/29/18

Fingerprint

Congenital Hyperinsulinism
Maple Syrup Urine Disease
Urine
Hypoglycemia
Isoleucine
Hyperinsulinism
Leucine
Blood Glucose
Insulin
Diazoxide
Amino Acids
Glucose
Branched Chain Amino Acids
Reproductive History
Mutation
Pancreatectomy
C-Peptide
Metabolic Diseases
Valine
Genetic Testing

Cite this

Al-Shidhani, A., AL-Yaarubi, S., AL-Murshedi, F., Ullah, I., & Al-Thihli, K. (2018). Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination. 359. Abstract from European society of pediatric endocrinology meeting 2018, Athens , Greece.

Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination. / Al-Shidhani, Azza; AL-Yaarubi, Saif; AL-Murshedi, Fathiya; Ullah, Irfan; Al-Thihli, Khalid.

2018. 359 Abstract from European society of pediatric endocrinology meeting 2018, Athens , Greece.

Research output: Contribution to conferenceAbstract

Al-Shidhani, A, AL-Yaarubi, S, AL-Murshedi, F, Ullah, I & Al-Thihli, K 2018, 'Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination' European society of pediatric endocrinology meeting 2018, Athens , Greece, 9/27/18 - 9/29/18, pp. 359.
Al-Shidhani A, AL-Yaarubi S, AL-Murshedi F, Ullah I, Al-Thihli K. Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination. 2018. Abstract from European society of pediatric endocrinology meeting 2018, Athens , Greece.
Al-Shidhani, Azza ; AL-Yaarubi, Saif ; AL-Murshedi, Fathiya ; Ullah, Irfan ; Al-Thihli, Khalid. / Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination. Abstract from European society of pediatric endocrinology meeting 2018, Athens , Greece.
@conference{a978060fd8cf42d9b0f3ead4715636aa,
title = "Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination",
abstract = "Background: Congenital hyperinsulinism (CHI) is the mostcommon cause of persistent hypoglycemia in infancy, characterized by unregulated insulin secretion. CHI is a challengingdisease to diagnose and manage. Moreover, complicating thecourse of the disease with another metabolic disease like Maplesyrup urine disease (MSUD) adds more challenges to the alreadycomplex management. Case: We report a term male neonate withuneventful birth history. He developed symptomatic hypoglycemia with a blood glucose (BG) level of 1.9 mmol/l at 21 hours oflife. A critical sample at that time showed high serum insulin of 167.7 pmol/L, C-peptide [1160 pmol/L and low ketonesconfirming the diagnosis of hyperinsulinism. Amino acid profileon dried blood spot by tandem mass spectrometry part of criticalsample was done and showed high leucine and isoleucine levelsindicating the diagnosis of MSUD. MSUD is then confirmed byHPLC which showed the presence of allo-isoleucine at101 umol/L, and elevated levels of the three branched chainamino acids (leucine 724 (45.00–160.00), isoleucine 240 umol/L(28.00–95.00), and valine 390 umol/L (60.00–294.00). Thediagnosis of CHI and MSUD was afterward confirmed bymolecular genetic testing. The finding of a known pathogenichomozygous mutation in the ABCC8 gene (c.3748COT,p.Arg1250*) confirmed CHI diagnosis. The presence of ahomozygous mutation in the BCKDHA (c.1087, p.Arg363Trp)confirmed the MSUD diagnosis. The baby’s case is verychallenging managing two rare autosomal recessive disorders.Managing his hypoglycemia with high glucose rate throughintravenous fluids, frequent feeds with special MSUD formula, andmedications for hyperinsulinism (Diazoxide and octereotide).Unfortunately his hyperinsulinism did not respond to all medicalmeasures and he needed to go to a near total pancreatectomy.Through all his complicated course, he required very meticulousmonitoring of his BG and amino acid profile (3 times/week onaverage) aiming to maintain the BG at 3.9 mmol and above andlevels of the three branched chain amino acids at the diseasetherapeutic targets for a neonate. Conclusion: This patient isperhaps the only known case of the occurrence of two rare lifethreatening disorders. Both hypoglycemia and Leucine encephalopathy can result in death or permanent neurological damage. Thisis complicated by the fact that both disorders have direct effect onthe body metabolism of glucose and branched chain amino acidsand there management in combination is very challenging",
author = "Azza Al-Shidhani and Saif AL-Yaarubi and Fathiya AL-Murshedi and Irfan Ullah and Khalid Al-Thihli",
year = "2018",
language = "English",
pages = "359",
note = "European society of pediatric endocrinology meeting 2018, ESPE 2018 ; Conference date: 27-09-2018 Through 29-09-2018",

}

TY - CONF

T1 - Congenital Hyperinsulinism and Maple Syrup Urine Disease a Challenging Combination

AU - Al-Shidhani, Azza

AU - AL-Yaarubi, Saif

AU - AL-Murshedi, Fathiya

AU - Ullah, Irfan

AU - Al-Thihli, Khalid

PY - 2018

Y1 - 2018

N2 - Background: Congenital hyperinsulinism (CHI) is the mostcommon cause of persistent hypoglycemia in infancy, characterized by unregulated insulin secretion. CHI is a challengingdisease to diagnose and manage. Moreover, complicating thecourse of the disease with another metabolic disease like Maplesyrup urine disease (MSUD) adds more challenges to the alreadycomplex management. Case: We report a term male neonate withuneventful birth history. He developed symptomatic hypoglycemia with a blood glucose (BG) level of 1.9 mmol/l at 21 hours oflife. A critical sample at that time showed high serum insulin of 167.7 pmol/L, C-peptide [1160 pmol/L and low ketonesconfirming the diagnosis of hyperinsulinism. Amino acid profileon dried blood spot by tandem mass spectrometry part of criticalsample was done and showed high leucine and isoleucine levelsindicating the diagnosis of MSUD. MSUD is then confirmed byHPLC which showed the presence of allo-isoleucine at101 umol/L, and elevated levels of the three branched chainamino acids (leucine 724 (45.00–160.00), isoleucine 240 umol/L(28.00–95.00), and valine 390 umol/L (60.00–294.00). Thediagnosis of CHI and MSUD was afterward confirmed bymolecular genetic testing. The finding of a known pathogenichomozygous mutation in the ABCC8 gene (c.3748COT,p.Arg1250*) confirmed CHI diagnosis. The presence of ahomozygous mutation in the BCKDHA (c.1087, p.Arg363Trp)confirmed the MSUD diagnosis. The baby’s case is verychallenging managing two rare autosomal recessive disorders.Managing his hypoglycemia with high glucose rate throughintravenous fluids, frequent feeds with special MSUD formula, andmedications for hyperinsulinism (Diazoxide and octereotide).Unfortunately his hyperinsulinism did not respond to all medicalmeasures and he needed to go to a near total pancreatectomy.Through all his complicated course, he required very meticulousmonitoring of his BG and amino acid profile (3 times/week onaverage) aiming to maintain the BG at 3.9 mmol and above andlevels of the three branched chain amino acids at the diseasetherapeutic targets for a neonate. Conclusion: This patient isperhaps the only known case of the occurrence of two rare lifethreatening disorders. Both hypoglycemia and Leucine encephalopathy can result in death or permanent neurological damage. Thisis complicated by the fact that both disorders have direct effect onthe body metabolism of glucose and branched chain amino acidsand there management in combination is very challenging

AB - Background: Congenital hyperinsulinism (CHI) is the mostcommon cause of persistent hypoglycemia in infancy, characterized by unregulated insulin secretion. CHI is a challengingdisease to diagnose and manage. Moreover, complicating thecourse of the disease with another metabolic disease like Maplesyrup urine disease (MSUD) adds more challenges to the alreadycomplex management. Case: We report a term male neonate withuneventful birth history. He developed symptomatic hypoglycemia with a blood glucose (BG) level of 1.9 mmol/l at 21 hours oflife. A critical sample at that time showed high serum insulin of 167.7 pmol/L, C-peptide [1160 pmol/L and low ketonesconfirming the diagnosis of hyperinsulinism. Amino acid profileon dried blood spot by tandem mass spectrometry part of criticalsample was done and showed high leucine and isoleucine levelsindicating the diagnosis of MSUD. MSUD is then confirmed byHPLC which showed the presence of allo-isoleucine at101 umol/L, and elevated levels of the three branched chainamino acids (leucine 724 (45.00–160.00), isoleucine 240 umol/L(28.00–95.00), and valine 390 umol/L (60.00–294.00). Thediagnosis of CHI and MSUD was afterward confirmed bymolecular genetic testing. The finding of a known pathogenichomozygous mutation in the ABCC8 gene (c.3748COT,p.Arg1250*) confirmed CHI diagnosis. The presence of ahomozygous mutation in the BCKDHA (c.1087, p.Arg363Trp)confirmed the MSUD diagnosis. The baby’s case is verychallenging managing two rare autosomal recessive disorders.Managing his hypoglycemia with high glucose rate throughintravenous fluids, frequent feeds with special MSUD formula, andmedications for hyperinsulinism (Diazoxide and octereotide).Unfortunately his hyperinsulinism did not respond to all medicalmeasures and he needed to go to a near total pancreatectomy.Through all his complicated course, he required very meticulousmonitoring of his BG and amino acid profile (3 times/week onaverage) aiming to maintain the BG at 3.9 mmol and above andlevels of the three branched chain amino acids at the diseasetherapeutic targets for a neonate. Conclusion: This patient isperhaps the only known case of the occurrence of two rare lifethreatening disorders. Both hypoglycemia and Leucine encephalopathy can result in death or permanent neurological damage. Thisis complicated by the fact that both disorders have direct effect onthe body metabolism of glucose and branched chain amino acidsand there management in combination is very challenging

M3 - Abstract

SP - 359

ER -